Abstract C189: CO-1686, an orally available, mutant-selective inhibitor of the epidermal growth factor receptor (EGFR), causes tumor shrinkage in non-small cell lung cancer (NSCLC) with T790M mutations.
暂无分享,去创建一个
Juswinder Singh | M. Nacht | M. Raponi | R. Petter | A. Walter | W. Westlin | A. Dubrovskiy | Andrew M. Allen | Zhendong Zhu | Kevin K. Lin | H. Haringsma | Robert Tjin | Kwangho Lee | T. Martin | R. Karp | Deqiang Niu | K. Lin